清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

医学 荟萃分析 梅德林 中止 不利影响 随机对照试验 安慰剂 心理干预 优势比 心理信息 精神科 物理疗法 内科学 替代医学 病理 法学 政治学
作者
Franco De Crescenzo,Gian Loreto D’Alò,Edoardo G. Ostinelli,Marco Ciabattini,Valeria Di Franco,Norio Watanabe,Ayse Kurtulmuş,Anneka Tomlinson,Zuzana Mitrova,Francesca Foti,Cinzia Del Giovane,Digby Quested,Philip J. Cowen,Corrado Barbui,Laura Amato,Orestis Efthimiou,Andrea Cipriani
出处
期刊:The Lancet [Elsevier BV]
卷期号:400 (10347): 170-184 被引量:254
标识
DOI:10.1016/s0140-6736(22)00878-9
摘要

BackgroundBehavioural, cognitive, and pharmacological interventions can all be effective for insomnia. However, because of inadequate resources, medications are more frequently used worldwide. We aimed to estimate the comparative effectiveness of pharmacological treatments for the acute and long-term treatment of adults with insomnia disorder.MethodsIn this systematic review and network meta-analysis, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, Embase, PsycINFO, WHO International Clinical Trials Registry Platform, ClinicalTrials.gov, and websites of regulatory agencies from database inception to Nov 25, 2021, to identify published and unpublished randomised controlled trials. We included studies comparing pharmacological treatments or placebo as monotherapy for the treatment of adults (≥18 year) with insomnia disorder. We assessed the certainty of evidence using the confidence in network meta-analysis (CINeMA) framework. Primary outcomes were efficacy (ie, quality of sleep measured by any self-rated scale), treatment discontinuation for any reason and due to side-effects specifically, and safety (ie, number of patients with at least one adverse event) both for acute and long-term treatment. We estimated summary standardised mean differences (SMDs) and odds ratios (ORs) using pairwise and network meta-analysis with random effects. This study is registered with Open Science Framework, https://doi.org/10.17605/OSF.IO/PU4QJ.FindingsWe included 170 trials (36 interventions and 47 950 participants) in the systematic review and 154 double-blind, randomised controlled trials (30 interventions and 44 089 participants) were eligible for the network meta-analysis. In terms of acute treatment, benzodiazepines, doxylamine, eszopiclone, lemborexant, seltorexant, zolpidem, and zopiclone were more efficacious than placebo (SMD range: 0·36–0·83 [CINeMA estimates of certainty: high to moderate]). Benzodiazepines, eszopiclone, zolpidem, and zopiclone were more efficacious than melatonin, ramelteon, and zaleplon (SMD 0·27–0·71 [moderate to very low]). Intermediate-acting benzodiazepines, long-acting benzodiazepines, and eszopiclone had fewer discontinuations due to any cause than ramelteon (OR 0·72 [95% CI 0·52–0·99; moderate], 0·70 [0·51–0·95; moderate] and 0·71 [0·52–0·98; moderate], respectively). Zopiclone and zolpidem caused more dropouts due to adverse events than did placebo (zopiclone: OR 2·00 [95% CI 1·28–3·13; very low]; zolpidem: 1·79 [1·25–2·50; moderate]); and zopiclone caused more dropouts than did eszopiclone (OR 1·82 [95% CI 1·01–3·33; low]), daridorexant (3·45 [1·41–8·33; low), and suvorexant (3·13 [1·47–6·67; low]). For the number of individuals with side-effects at study endpoint, benzodiazepines, eszopiclone, zolpidem, and zopiclone were worse than placebo, doxepin, seltorexant, and zaleplon (OR range 1·27–2·78 [high to very low]). For long-term treatment, eszopiclone and lemborexant were more effective than placebo (eszopiclone: SMD 0·63 [95% CI 0·36–0·90; very low]; lemborexant: 0·41 [0·04–0·78; very low]) and eszopiclone was more effective than ramelteon (0.63 [0·16–1·10; very low]) and zolpidem (0·60 [0·00–1·20; very low]). Compared with ramelteon, eszopiclone and zolpidem had a lower rate of all-cause discontinuations (eszopiclone: OR 0·43 [95% CI 0·20–0·93; very low]; zolpidem: 0·43 [0·19–0·95; very low]); however, zolpidem was associated with a higher number of dropouts due to side-effects than placebo (OR 2·00 [95% CI 1·11–3·70; very low]).InterpretationOverall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed drugs did not show overall material benefits. These results should serve evidence-based clinical practice.FundingUK National Institute for Health Research Oxford Health Biomedical Research Centre.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
梓树完成签到,获得积分10
2秒前
alanbike完成签到,获得积分10
3秒前
WRX发布了新的文献求助10
4秒前
chen完成签到,获得积分10
6秒前
2316690509完成签到 ,获得积分10
8秒前
研友_ZG4ml8完成签到 ,获得积分10
14秒前
银海里的玫瑰_完成签到 ,获得积分10
21秒前
xiaowuge完成签到 ,获得积分10
25秒前
量子星尘发布了新的文献求助10
34秒前
氟锑酸完成签到 ,获得积分10
35秒前
小叙完成签到 ,获得积分10
36秒前
帅气的沧海完成签到 ,获得积分10
36秒前
Boris完成签到 ,获得积分10
37秒前
荣浩宇完成签到 ,获得积分10
41秒前
zhuosht完成签到 ,获得积分10
43秒前
V_I_G完成签到 ,获得积分10
44秒前
李健应助WRX采纳,获得10
46秒前
48秒前
YuLu完成签到 ,获得积分10
49秒前
54秒前
ww发布了新的文献求助10
54秒前
55秒前
落忆完成签到 ,获得积分10
1分钟前
Ortho完成签到 ,获得积分10
1分钟前
mzhang2完成签到 ,获得积分10
1分钟前
yangching完成签到,获得积分10
1分钟前
wujuan1606完成签到 ,获得积分10
1分钟前
1分钟前
蚂蚁踢大象完成签到 ,获得积分10
1分钟前
planto完成签到,获得积分10
1分钟前
乐乐完成签到 ,获得积分10
1分钟前
个性的翠芙完成签到 ,获得积分10
1分钟前
adamchase完成签到 ,获得积分10
1分钟前
mojojo完成签到 ,获得积分10
1分钟前
隐形松完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
2分钟前
飞龙在天完成签到 ,获得积分10
2分钟前
Denning完成签到,获得积分10
2分钟前
2分钟前
WRX发布了新的文献求助10
2分钟前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
宽量程高线性度柔性压力传感器的逆向设计 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3980994
求助须知:如何正确求助?哪些是违规求助? 3524672
关于积分的说明 11222589
捐赠科研通 3262273
什么是DOI,文献DOI怎么找? 1801153
邀请新用户注册赠送积分活动 879609
科研通“疑难数据库(出版商)”最低求助积分说明 807449